Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 6, Pages e39486
Publisher
Public Library of Science (PLoS)
Online
2012-06-21
DOI
10.1371/journal.pone.0039486
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: a preliminary report
- (2011) Kang Yao et al. Cardiovascular Diabetology
- The role of dysregulated glucagon secretion in type 2 diabetes
- (2011) D. D'Alessio DIABETES OBESITY & METABOLISM
- Italian pediatric data support hypothesis that simultaneous epidemics of type 1 diabetes and type 2 diabetes/metabolic syndrome/obesity are polar opposite responses (i.e., symptoms) to a primary inflammatory condition
- (2011) John B. Classen JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- Hyperglycemic Myocardial Damage Is Mediated by Proinflammatory Cytokine: Macrophage Migration Inhibitory Factor
- (2011) Xi-Yong Yu et al. PLoS One
- Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients
- (2011) Sung-Tae Kim et al. Diabetes & Metabolism Journal
- Hepatocyte growth factor is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients
- (2010) Futoshi Anan et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients
- (2010) Pei-chun Chao et al. EUROPEAN JOURNAL OF NUTRITION
- Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy
- (2010) Chao-Hung Hung et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment
- (2010) Giuseppe Castello et al. Journal of Translational Medicine
- Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus
- (2010) Hiroyuki Konya et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis
- (2009) Valérie Paradis et al. HEPATOLOGY
- Adipokines in liver diseases
- (2009) Fabio Marra et al. HEPATOLOGY
- IL-6 and IL-18 in Blood May Discriminate Cirrhotic Patients With and Without Minimal Hepatic Encephalopathy
- (2009) Carmina Montoliu et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The Met tyrosine kinase receptor in development and cancer
- (2008) Alessandra Gentile et al. CANCER AND METASTASIS REVIEWS
- Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancer
- (2008) Mario Fusco et al. EUROPEAN JOURNAL OF CANCER
- Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
- (2008) Chi–Ling Chen et al. GASTROENTEROLOGY
- Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus
- (2008) Bart J. Veldt et al. HEPATOLOGY
- Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis
- (2008) Arpita Sharma et al. IMMUNOLOGY
- Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patients
- (2008) Yoshiyuki Takahara et al. WORLD JOURNAL OF GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started